$HSCS News

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

Heart Test Laboratories Q4 EPS $(0.87) Misses $(0.73) Estimate

Zcash Miner Fortitude Merging with HeartSciences to Go Public

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

Fortitude Mining, HeartSciences Strike Merger Deal; Combined Entity Anticipated To Trade On Nasdaq Under TUDE Ticker

European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

HeartSciences Announces Commercial Release Of MyoVista Insights Version 1.3, Platform Update Introducing MyoVista Insights AI-ECG Algorithm Marketplace

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

HeartSciences Signs Commercial Agreement With St. Vincent Health, Critical Access Hospital Serving Lake County, Colorado, To Deploy MyoVista Insights Platform

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $8

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Heart Test Laboratories Q3 EPS $(0.63) Beats $(0.86) Estimate

University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals